MedTrace Logo

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects

NCT01719419 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-12-18

No results posted yet for this study

Summary

The purpose of this study is to determine if the drug orlistat (Alli, Xenical) decreases the taste for fat in humans.

Conditions

Interventions

DRUG

Placebo

Measured fatty food intake and appetite at a single lunch meal after the administration of modified sham feeding technique with placebo.

DRUG

Orlistat

Measured fatty food intake and appetite at a single lunch meal after the administration of modified sham feeding technique with orlistat.

Sponsors & Collaborators

  • Pennington Biomedical Research Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01719419 on ClinicalTrials.gov